Ana Marie Rodriguez Barreto
Clinical Genetics (M.D.) · Miami, FLNPI 1447785530
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations.
Across 39 payments — averaging $28.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$206
- Sanofi$177
- NS Pharma, Inc.$105
- Ultragenyx Pharmaceutical Inc.$75
- Soleno Therapeutics, Inc.$67
- Sanofi Pasteur Inc.$47
- plus $434 from 14 others
Across 1 payment — averaging $20,930 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$21K
What the payments were for
- Food & beverage$1,110100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 4 | $206 |
| Sanofi | 6 | $177 |
| NS Pharma, Inc. | 4 | $105 |
| Ultragenyx Pharmaceutical Inc. | 3 | $75 |
| Soleno Therapeutics, Inc. | 2 | $67 |
| Sanofi Pasteur Inc. | 2 | $47 |
| Mirum Pharmaceuticals, Inc. | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Cycle Pharmaceuticals Inc | 2 | $38 |
| UCB, Inc. | 1 | $34 |
| Rhythm Pharmaceuticals, Inc. | 1 | $33 |
| PTC Therapeutics, Inc. | 1 | $31 |
| AstraZeneca | 1 | $29 |
| Travere Therapeutics, Inc. | 1 | $26 |
| Acadia Pharmaceuticals Inc | 1 | $25 |
| Immedica Pharma US, Inc. | 1 | $24 |
| Albireo Pharma, Inc. | 1 | $24 |
| Sentynl Therapeutics, Inc. | 1 | $21 |
| Biogen | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOXZOGO 1.2mg$118
How this compares
$1,110 in reported general payments places this provider in the 70th percentile of 37 clinical genetics (m.d.) providers in Florida.
Other clinical genetics (m.d.) in Miami
- Parul JayakarMiami$82K
- Deborah BarbouthMiami$40K
- Irman ForghaniMiami$3K
- Sajel LalaMiami$2K
- Thelma SugranesMiami$1K
- Paul CardenasMiami$343
- Sofia CatenaMiami$229
- Willa ThorsonMiami$71
- Mustafa TekinMiami$52
- Nicholas BorjaMiami$41
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.